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Abstract
Background: Rubella virus (RV) infection is usually a mild illness in children and adults. However, maternal infection
during the first trimester of pregnancy can lead to congenital rubella syndrome (CRS) in the infant. Fetuses with CRS
show damage to the endothelium of the heart and blood vessels; thus, it has been speculated that the clinical
manifestations associated with CRS may be a result of endothelial cells persistently infected with RV. Here, we
compared the effects of RV infection on gene expression in primary endothelial cells of fetal (HUVEC) and of adult
(HSaVEC) origin by transcriptional profiling.
Results: More than 75 % of the genes differentially regulated following RV infection were identical in both cell
types. Gene Ontology (GO) analysis of these commonly regulated genes showed an enrichment of terms involved
in cytokine production and cytokine regulation. Increased accumulation of inflammatory cytokines following RV
infection was verified by protein microarray. Interestingly, the chemokine CCL14, which is implicated in supporting
embryo implantation at the fetal-maternal interface, was down-regulated following RV infection only in HUVEC.
Most noticeably, when analyzing the uniquely regulated transcripts for each cell type, GO term-based cluster
analysis of the down-regulated genes of HUVEC revealed an enrichment of the GO terms “sensory organ
development”, “ear development” and “eye development”.
Conclusion: Since impairment in vision and hearing are the most prominent clinical manifestations observed in
CRS patients, the here detected down-regulated genes involved in the development of sensory organs sheds light
on the molecular mechanisms that may contribute to the teratogenic effect of RV.
Keywords: Rubella virus, Congenital rubella syndrome, Gene expression, Sensory organ development,
Teratogenicity, Endothelial cells
Background
Rubella virus (RV) is a single-stranded RNA virus of posi-
tive polarity and belongs to the family Togaviridae. RV in-
fection typically causes mild symptoms such as rash and
fever in children and adults; however, its teratogenicity is
still a public health concern. Maternal infection early in
pregnancy can lead to a combination of birth defects in in-
fants, collectively called congenital rubella syndrome
(CRS) [1, 2]. Transplacental transmission of the virus is
high in the first weeks of gestation [3], and if infection
occurs, the virus is able to infect almost any organ, thereby
establishing a chronic infection in the developing fetus [4].
In RV-infected embryos and fetuses, vascular abnormalities,
such as lesions in the endothelium of the heart and blood
vessels, have been described as the most frequently ob-
served pathological findings [5–8]. Common clinical mani-
festations associated with CRS are patent ductus arteriosus,
pulmonary artery stenosis and valvular stenosis [9]. Other
frequently observed defects include cataracts, glaucoma,
sensorineural deafness and psychomotor retardation [10].
Despite the introduction of an effective vaccine and global
vaccination programs, approximately 110,000 CRS cases
are estimated to still occur worldwide per year [11].
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RV infection during the critical stages of organ devel-
opment and in a setting where a mature immune system
is absent is believed to account for the clinical manifes-
tations of CRS. However, the exact molecular mecha-
nisms by which RV causes CRS are still poorly
understood. Previous work has shown that RV interferes
with cellular proliferative pathways, alters cytoskeletal
structures, and induces mitochondrial changes, leading
to the hypothesis that virus-induced apoptosis contrib-
utes to the teratogenic effects of RV (reviewed in J. Y.
Lee and D. S. Bowden [12] and D. M. Knipe and P. M.
Howley [13]). However, most of these findings are de-
rived from studies using immortalized adult cell lines
(e.g. Vero, A549, and BHK-21 cells). These cell lines dif-
fer considerably from fetal cells in vivo in terms of gene
expression, metabolism, and growth rate, and therefore
give only limited insight into the effects of RV infection
during embryonic development.
Microarray gene expression analysis provides a valuable
tool to comprehensively examine and identify pathways
that are affected by virus infection. Previous transcrip-
tional profiling analysis following RV infection of primary
human fibroblasts derived from a whole embryo [14], as
well as the ECV304 cell line which exhibit both endothe-
lial and epithelial characteristics [15], revealed that RV in-
duces a robust interferon-stimulated gene response.
However, since endothelial cells are believed to play a
major role in RV-induced teratogenesis, our studies fo-
cused on the gene expression changes of an infection
caused by a wild type RV isolate (Wuerzburg-12) in pri-
mary fetal endothelial cells derived from the human um-
bilical vein (HUVEC) and adult endothelial cells derived
from the human saphenous vein (HSaVEC). By comparing
up- and down-regulated genes in the endothelial cells of
fetal and adult origin using Gene ontology (GO) term ana-
lysis, we were able to identify differences in biological pro-
cesses and pathways between HUVEC and HSaVEC. We
believe that these differences in gene expression after in-
fection of endothelial cells of adult and fetal origin provide
new insights into the molecular mechanisms involved in
RV-induced teratogenicity.
Results
Primary endothelial cells are permissive for RV
RV is characterized by a relatively slow replication cycle
[16, 17] and has been shown to infect different cell types
asynchronously, even at a high MOI [14, 18]. However,
L. Perelygina, et al. [19] found that RV infection at an
MOI ≥ 10 produced synchronously infected HUVEC
cultures. To determine the optimal time point for gene
expression analyses and in order to see if HSaVEC are
also synchronously infected, viral replication was ana-
lyzed by growth curves and viral capsid protein levels
were determined by flow cytometry. The immortalized
cell lines Vero76 and A549 have been used successfully
for producing high RV titers [13] and were therefore
used as controls in the following experiments. Growth
kinetics showed that RV effectively replicates in the
monolayer of fetal and adult primary endothelial cells.
Comparable titers were observed after infection of
HUVEC, A549, and Vero76; the infection of HSaVEC
produced slightly lower viral titers (Fig. 1(a)). However,
the viral titer remained almost constant during the ob-
servation period of five days for all cell types. Since it
has been shown that the efficiency of RV egress is
strongly dependent on the cell line [20], we quantified
the titers of both extracellular and cell-associated virus,
revealing that a similar amount of extracellular and cell-
associated virus was produced in Vero76 cells. In con-
trast, the amount of extracellular virus was approxi-
mately one log higher in the supernatant than cell-
associated in HUVEC, HSaVEC, and A549 cells. This is
in accord with previous studies and suggests a more effi-
cient viral egress in human cell lines [19]. Only moder-
ate cytopathic effects (CPE), such as cell rounding and
detachment, were detectable for all cell types two days
post infection (dpi) (Fig. 1 (b)).
In contrast to L. Perelygina, et al. [19] we did not de-
tect synchronous infection in HUVEC by flow cytometry
(Fig. 1 (c)). Approximately one fourth of the primary
endothelial cells were RV capsid positive 23 h post infec-
tion (hpi). Capsid protein levels increased over time,
reaching about 50 % of capsid positive cells in the pri-
mary endothelial cells 48 hpi. Interestingly, immortalized
cell lines Vero76 and A549 cells expressed more viral
capsid than HUVEC and HSaVEC, indicating that RV is
able to infect these cell lines more efficiently.
Similar changes in gene expression pattern after RV
infection of fetal and adult endothelial cells
The viral life cycle of RV is completed approximately 24
hpi [16, 19]. Due to asynchronous infection of the pri-
mary endothelial cells, and in order to have a relatively
high number of infected primary endothelial cells while
still avoiding multiple viral life cycles, 36 hpi was chosen
for analysis of gene expression. HUVEC and HSaVEC
were infected in triplicate with the clinical isolate Wb-12
at an MOI of 10. Non-infected cells served as the con-
trol. Total RNA was harvested 36 hpi and was used for
microarray analysis of host cell transcription. To com-
pare the gene expression of infected and non-infected
cells, ratios were calculated by using normalized signal
intensities of infected- and non-infected cells. Genes that
exhibited a fold change in gene expression ≥ 4 and ≤ −4
with an ANOVA p-value of ≤ 0.01 were chosen for fur-
ther analysis (Additional file 1).
Gene expression data of virus-infected to non-infected
cells were compared to each other to determine the
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Fig. 1 RV replication in primary endothelial cells and RV-permissive cell lines. a RV replication kinetics in HUVEC, HSaVEC, Vero76, and A549 cells.
Cells were infected with RV at an MOI of 5. At the indicated time points, cell culture supernatants or cell lysates were titered in duplicate on
Vero76 cells. The data are represented as the mean of two independent experiments ± standard deviation (SD). The data were analyzed by two-
way ANOVA with the Bonferroni correction for multiple comparisons (*, p≤ 0.05; **, p≤ 0.01; ***, p≤ 0.001). b Phase contrast pictures of non-in-
fected cells or cells infected with RV with an MOI of 10 two dpi. c Capsid protein levels of RV-infected cell types at various time points post infection.
Cells were infected with an MOI of 5 and harvested at the indicated time points and analyzed by flow cytometry. Intracellular staining was carried out
using a capsid-specific antibody and anti-mouse-Cy5 serum as a secondary antibody. Non-infected cells served as the control. All experiments were
performed three times. Error bars represent means ± SD
Fig. 2 Common changes in cellular gene expression after RV infection in fetal and adult endothelial cells. a Displayed are the percent of genes
that exhibited expression changes greater than or equal to 4-fold with an ANOVA p-value of≤ 0.01. The percentage is based on the total amount
of genes assayed. b Venn diagram showing the intersection between the up-regulated (↑), down-regulated (↓) and contra-egulated (↕) transcripts 36 h
after RV infection (MOI of 10) of HUVEC and HSaVEC. c Biological process and d KEGG pathway analysis of the 392 transcripts that were affected
after RV infection in both fetal and adult endothelial cells. Displayed are the ranked Bonferroni corrected p-values of significantly enriched
biological processes and pathways (p ≤ 0.01). Related terms were grouped and the most significant term of the group was defined as the
group leading term. Numbers at the bar represent genes (in %) from the cluster that were associated with the term
Geyer et al. Virology Journal  (2016) 13:21 Page 4 of 17
relative modulation of cellular transcription induced by
RV infection. Of the 38,500 human genes assayed, 834
(2.2 %) and 769 (2.0 %) genes were differentially regu-
lated in HUVEC and HSaVEC, respectively (Fig. 2 (a)).
In HUVEC, 563 genes were up-regulated and 271 were
down-regulated following RV infection. Similarly, in
HSaVEC, 621 genes were up-regulated and 148 were
down-regulated. A comparison of the number of differen-
tially regulated genes in both endothelial cells showed an
overlap of more than 75 % (Fig. 2 (b)). Of the overlapping
genes, five genes were contra-regulated. Remarkably, a lar-
ger proportion of genes were down-regulated in HUVEC
after RV infection compared to HSaVEC.
Due to the high overlap of genes which are affected
by RV infection in HUVEC and HSaVEC, we wanted
to know whether certain biological processes and cel-
lular pathways were statistically overrepresented. GO
term-based analysis of the 392 commonly regulated
genes was applied. As shown in Fig. 2 (c), fourteen
biological processes were enriched in the endothelial
cells. Remarkably, a large proportion of genes were
assigned to GO terms involved in cytokine production
and regulation. Furthermore, GO terms involved in
cellular defense mechanisms were enriched in infected
HUVEC and HSaVEC. In addition to GO term-
analysis, KEGG pathway analysis (Fig. 2 (d)) revealed
Table 1 Differentially expressed genes of the chemokine family
Gene symbol Gene title Mean fold change(a)
HUVEC HSaVEC
CCL2 chemokine (C-C motif) ligand 2 21.03 n.s.
CCL20 chemokine (C-C motif) ligand 20 112.23 122.14
CCL23 chemokine (C-C motif) ligand 23 4.32 4.09
CCL3, CCL3L1, CCL3L3 chemokine (C-C motif) ligand 3;
chemokine (C-C motif) ligand 3-like
1; chemokine (C-C motif) ligand 3-like 3
194.09 278.09
CCL4 chemokine (C-C motif) ligand 4 231.15 972.27
CCL5 chemokine (C-C motif) ligand 5 1394.87 430.3
1254.72 325.72
414.38 310.81
CCL7 chemokine (C-C motif) ligand 7 115.92 n.s.
CCL8 chemokine (C-C motif) ligand 8 579.29 151.42
CX3CL1 chemokine (C-X3-C motif) ligand 1 23.37 36.99
12.43 28.53
CXCL1 chemokine (C-X-C motif) ligand 1 5.59 n.s.
CXCL10 chemokine (C-X-C motif) ligand 10 4833.33 297.78
CXCL11 chemokine (C-X-C motif) ligand 11 382.38 72.25
CXCL12 chemokine (C-X-C motif) ligand 12 35.66 n.s.
7.43
CXCL16 chemokine (C-X-C motif) ligand 16 8.68 6.29
CXCL2 chemokine (C-X-C motif) ligand 2 28.56 4.70
25.62 4.18
22.74
CXCL3 chemokine (C-X-C motif) ligand 3 92.97 33.14
CXCL5 chemokine (C-X-C motif) ligand 5 44.83 15.34
22.63 12.55
12.1
CXCL6 chemokine (C-X-C motif) ligand 6 84.27 8.97
CXCL9 chemokine (C-X-C motif) ligand 9 41.56 88.71
(a)Displayed are average fold change of RV-infected cells in comparison to non-infected cells detected by transcriptome analysis. In positions that are labeled n.s.,
the gene expression did not meet the selected criteria (i.e. fold change cut-off ≤ −4 and ≥ 4 and ANOVA p-value of ≤ 0.01). If a gene was detected by several
different probes, all fold changes that meet the selected criteria are shown
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the enrichment of pathways which are involved in
antiviral responses, such as the Toll-like receptor sig-
naling pathway and the RIG-I-like receptor signaling
pathway.
Similar chemokine expression pattern after RV infection in
fetal and adult endothelial cells
Chemokines are chemotactic cytokines that play an im-
portant role during inflammation and homeostasis. While
inflammatory chemokines are required to recruit immune
cells to the site of infection, homeostatic chemokines pos-
sess a key function in controlling cell migration during de-
velopmental processes. Interference with the precisely
coordinated production of chemokines triggered by a viral
infection has profound effects on fetal development and is
speculated to contribute to the pathological findings of
CRS [14].
Our GO term analysis revealed that biological pro-
cesses involved in cytokine production, regulation, and
processing are enriched in both adult and fetal primary
endothelial cells. Moreover, gene expression was strongly
increased for the interferon-inducible chemokines
(Table 1). To verify up-regulation of these chemokines
on the protein level, HUVEC and HSaVEC were infected
at an MOI of 10 with RV and the chemokine levels in
the supernatant were quantified with a protein array at
48 hpi (Fig. 3). Similar to the microarray results, signifi-
cantly increased amounts of CCL2, CCL3, CCL4, CCL5,
Fig. 3 Impact of RV infection on chemokine secretion. HUVEC and HSaVEC were infected with RV at an MOI of 10 and the cell culture
supernatant was collected 48 hpi. Chemokine levels in the supernatant were determined using a human chemokine array kit. Changes in
chemokine concentration after RV infection are shown as the fold change compared to uninfected cells. Dotted lines indicate the thresholds that
were chosen for the experiment (fold change≥ 2 and≤ 0.5). Data are represented as the mean of two independent experiments ± SD
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CCL15, CCL20, CCL26, CXCL10, CXCL11 and CX3CL1
were detected in the supernatant following RV infection
in both HUVEC and HSaVEC. The overall pattern of
chemokine production before and after infection was
similar in the endothelial cells (Additional file 2). Inter-
estingly, one chemokine, CCL14, appeared to be secreted
at significantly lower amounts into the supernatant fol-
lowing RV infection of HUVEC.
Identification of differentially regulated genes induced by
RV in fetal and adult cells
In order to identify biological processes which are differ-
entially regulated after RV infection of primary cells of
adult and fetal origin, GO term-based cluster analysis
was carried out with genes that were up- or down-
regulated following infection compared to non-infected
cells. Figure 4 shows the GO terms that were signifi-
cantly (p ≤ 0.01) over-represented in the set of genes that
were up- or down-regulated after RV infection of
HUVEC and HSaVEC. Displayed are the Bonferroni cor-
rected p-values, with the numbers at the bar represent-
ing the percentage of genes from the cluster that were
associated with the term (compared with all genes asso-
ciated with the term). In addition to genes involved in
immune defense processes, genes associated with angio-
genesis and vascular development were over-represented
following RV infection in the up-regulated gene list of
HSaVEC. No GO terms were over-represented in the
down-regulated gene list of HSaVEC. In the set of genes
up-regulated in HUVEC following RV infection, GO
terms involved in immune processes were over-
represented. Moreover, the GO term “negative regulation
of immune effector processes” was also over-represented
in this set of genes, indicating that genes are activated
upon infection that counteract the cellular immune re-
sponse. Interestingly, 18 genes assigned to the GO term
“sensory organ development”, “eye development”, and
“ear development” were over-represented in the set of
down-regulated genes of HUVEC, but not HSaVEC.
Heart malformation, deafness and ocular conditions such
as cataracts are the most common clinical manifestations
of CRS, however the molecular mechanisms that lead to
the pathological conditions (or the gene products in-
volved) are not known. Table 2 summarizes the fold
Fig. 4 Bonferroni corrected p-values of significantly enriched biological processes which are unique to the two primary cells following RV infec-
tion. Related terms were merged into functional groups and the most significant term was defined as the group-leading term. Numbers at the
bar represent genes (in %) from the cluster that were associated with the term. Unfilled bars indicate if the GO term is derived from the down-
regulated gene list of HUVEC. Filled bars indicate if the GO term is derived from the up-regulated gene list of HUVEC (grey) and HSaVEC (black)
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changes of the down-regulated sensory organ develop-
ment genes as detected by microarray analysis for HUVEC
and HSaVEC. Four of the 18 genes that were down-
regulated in HUVEC were also down-regulated in HSa-
VEC. The remaining 14 genes were either unaffected or
up-regulated following infection in these cells.
In order to elucidate the putative molecular processes
leading to pathogenesis, we sought to verify the down-
regulated expression of genes assigned to the GO term
“sensory organ development” by qPCR. Therefore,
HUVEC and HSaVEC were infected with Wb-12 at an
MOI of ten and total RNA was isolated 36 hpi and
subjected to qPCR. For HUVEC, two pools of cells were
utilized for five independent experiments; whereas for
HSaVEC, two donors were used for six independent ex-
periments. Non-infected cells served as the control and
GAPDH was used for normalization. Analysis of gene
expression by qPCR was carried out with 13 genes ac-
cording to the ΔΔCT method. Of the 13 genes belonging
to this GO term, qPCR was able to confirm the down-
regulation of CLN8, FGFR2, FZD3, JAG2, MYO7A, NHS,
NOG and SLC25A27 in infected HUVEC (Fig. 5). Down-
regulation was verified for FZD3, NOG and SLC25A27
in infected HSaVEC; the other ten sensory organ devel-
opment genes were either up-regulated or not affected
in this cell type.
Differences in gene expression between HUVEC and
HSaVEC following RV infection might arise due to sig-
nificant differences in basal gene expression. In order to
rule this out for the selected sensory organ development
genes, the basal expression levels of non-infected endo-
thelial cells were compared with each other (Table 3).
Based on our selected criteria (i.e. fold change cut-off ≤ −4
and ≥ 4 and ANOVA p-value of ≤ 0.01) only the basal gene
expression level of ADAMTS18 was significantly lower
and NHS was significantly higher in HUVEC compared to
HSaVEC. Thus, we cannot completely rule out for these
genes that the observed differences following RV infection
between the primary endothelial cells might be the result
of differences in basal expression rates. However, for the
remaining eleven other genes examined, no differences in
basal gene expression were seen.
Table 2 Differential expression of genes belonging to the GO term “sensory organ development” in HUVEC and HSaVEC following
RV infection
Gene symbol Gene title Fold change microarray (a)
HUVEC HSaVEC
ADAMTS18 ADAM metallopeptidase with thrombospondin
type 1 motif, 18
−4.89 n.s.
ALDH1A2 aldehyde dehydrogenase 1 family, member A2 −4.16 n.s.
CLN8 ceroid-lipofuscinosis, neuronal 8 −8.05 n.s.
DSCAM Down syndrome cell adhesion molecule −9.98 n.s.
FGFR2 fibroblast growth factor receptor 2 −10.01 5.03
FZD3 frizzled family receptor 3 −10.00 −8.56
JAG2 jagged 2 −4.86 n.s.
−4.01
MYO3A myosin 3A −9.46 n.s.
MYO7A myosin 7A −5.65 −6.17
NHS Nance-Horan syndrome −4.35 n.s.
NOG noggin −6.68 −5.04
NTRK3 neurotrophic tyrosine kinase, receptor, type 3 −7.70 n.s.
PDGFRA platelet-derived growth factor receptor, alpha
polypeptide
−6.24 n.s.
RDH10 retinol dehydrogenase 10 (all-trans) −9.00 n.s.
SLC25A27 solute carrier family 25, member 27 −16.78 n.s.
TNPO1 transportin 1 −7.66 n.s.
TRPM1 transient receptor potential cation channel,
subfamily M, member 1
−7.72 −5.76
TSPAN12 tetraspanin 12 −4.42 n.s.
aDisplayed are the average fold changes from three independent experiments of RV-infected cells in comparison to non-infected cells detected by the microarray
that meet the selected criteria (i.e. fold change cut-off ≤ −4 and ≥ 4 and ANOVA p-value of ≤ 0.01). If a gene was detected by several different probes, all fold
changes that meet the selected criteria are shown. Positions labeled n.s. where not shown to be significantly up- or down-regulated in the DNA
microarray analysis
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Primary cells are thought to be a good model for
studying viral infections. However, these cells have been
shown to exhibit significant donor-to-donor variability
in some biological aspects. Although two pools of
HUVEC and HSaVEC from two different donors were
used for qPCR, we wanted to ensure that the observed
effects are not unique to a certain donor. Thus, we com-
pared the levels of sensory organ gene expression follow-
ing RV infection with cells from different donors. Fig. 6
compares the ΔΔCT values obtained from infections
with two pools of HUVEC — with each pool of cells
consisting of three different donors. The expression of
FZD3, NHS, NOG and TSPAN12 differed significantly
between the two pools of cells following infection. Des-
pite the significant difference, the direction of regulation
(i.e. down-regulation) was the same for FZD3, NHS and
NOG between the pools of cells. Thus, down-regulation
of the sensory organ development genes could be ob-
served for the majority of genes in HUVEC derived from
different donors, suggesting that the observed effects on
expression were not donor specific.
Since pooled HSaVEC are not commercially available
and the number of donors is limited, the expression
changes for two individual donors were compared and
showed a significant difference between donor 1 and 2
for NHS. However, the remaining twelve sensory organ
development genes did not differ between the two do-
nors following RV infection (Fig. 7).
Discussion
Cardiovascular abnormalities, sensorineural hearing loss,
cataracts, and glaucoma have been the most prominent
findings among patients suffering from CRS [8]. Although
RV has been shown to efficiently replicate in endothelial
cells [19], and was also found in the endothelium of in-
fected fetuses [6, 7, 9], studies with human endothelial
cells are scarce. Most research was conducted with non-
human cell lines, such as Vero, BHK and RK13.
Since it has been speculated that endothelial cells play
an important role in the birth defects associated with
CRS, we wanted to explore the effect of RV infection on
primary human endothelial cells of adult and fetal origin
by gene expression analysis. HUVEC are considered fetal
cells because they are derived from the umbilical cord
veins, which develop genetically and physiologically from
the fetus. In contrast to that, HSaVEC are derived from
the saphenous vein of adult donors. By analyzing the ef-
fects of RV replication on fetal and adult endothelial cells
we approched to understand the mechanisms underlying
RV-induced teratogenesis.
Efficient replication of RV in endothelial cells was
previously reported for HUVEC [19], but not for HSa-
VEC. Therefore, the primary endothelial cells were ana-
lyzed for their ability to support viral replication, in
addition to the Vero76 and A549 cell lines (which have
been routinely used to cultivate RV). The replication
kinetics and the detection of viral proteins showed that
RV replicates both in fetal and adult primary endothe-
lial cells. RV infection of HUVEC resulted in slightly
lower extracellular titers compared to the infection of
the immortalized cell lines Vero76 and A549. The
extracellular titers after infection of HSaVEC were about
10-fold reduced, which might be caused by the slower
growth rate of this cell line. However, viral titers
remained almost constant for the observation period of
five days after infection with an MOI of five, indicating
that the virus caused a persistent infection in the im-
mortalized cell lines as well as in the primary endothe-
lial cells. The results of the capsid expression analysis show
that the immortalized cell lines Vero76 and A549 are in-
fected more efficiently by RV than HUVEC and HSaVEC by
a factor of almost two. Synchronous infection has not been
observed in any of the cell lines after infection at anMOI of
(See figure on previous page.)
Fig. 5 Differential expression of genes belonging to the GO term “sensory organ development” in HUVEC and HSaVEC following RV infection as
determined by qPCR. HUVEC and HSaVEC from different donors were infected with RV at an MOI of 5 and gene expression relative to non-
infected cells was quantified by qPCR 36 hpi. GAPDH was used for normalization. Bars denote mean fold change (FC, n = 5 for HUVEC and n = 6
for HSaVEC) with confidence intervals calculated by the ΔΔCT mathematical model. A one-tailed paired t-test was used to determine statistically
significant differences in gene expression compared to non-infected cells using ΔCT values and is indicated by an asterisk and red coloring
(*, p≤ 0.05; **, p≤ 0.01)
Table 3 Basal expression of genes belonging to the GO term “sensory organ development” in HUVEC and HSaVEC
Gene
symbol
Gene title Fold Change HUVEC vs
HSaVEC(a)
ANOVA p-value HUVEC vs
HSaVEC(b)
ADAMTS18 ADAM metallopeptidase with thrombospondin type 1 motif,
18
−5.87 0.000027
NHS Nance-Horan syndrome 5.43 0.000766
(a)Displayed are the average fold changes from three independent experiments of non-infected HUVEC in comparison to non-infected HSaVEC detected by
microarray that meet the selected criteria (i.e. fold change cut-off ≤ −4 and ≥ 4 and ANOVA p-value of ≤ 0.01)
(b)ANOVA p-values ≤ 0.01 are considered significant
Geyer et al. Virology Journal  (2016) 13:21 Page 10 of 17
Fig. 6 (See legend on next page.)
Geyer et al. Virology Journal  (2016) 13:21 Page 11 of 17
5, which is consistent with findings in other various cell
lines [14, 17, 18, 21]. In one other study, infection of
HUVEC with a clinical isolate of a different genotype
(1E) has been shown to be synchronous at a high MOI
[19]. Possibly, different RV strains may have distinct ef-
ficiencies and properties regarding infection or different
cellular tropisms. Since RV-infected HUVEC and HSa-
VEC with similar efficiencies, it is reasonable to assume
that the virus generally does not have a stronger trop-
ism for fetal cells than for adult cells.
The aim of the present study was to identify differ-
ences in the gene expression pattern following RV infec-
tion in fetal and adult primary cells in order to
understand the teratogenicity of the virus. More than
75 % of the differentially regulated genes following RV
infection overlapped between HUVEC and HSaVEC cells
indicating similar gene expression modulation following
RV infection. Not surprisingly, these genes were grouped
to GO terms involved in host defense mechanisms, such
as cytokine regulation and production. M. P. Adamo, et
al. [14] and X. Y. Mo, et al. [15] reported a robust
interferon-stimulated gene response following infection
of human embryonic fibroblasts and the ECV304 cell line,
respectively. This is corroborated by our findings, since
expression of interferon-inducible genes, such as OASL
and MX2, was strongly upregulated following RV infec-
tion. Moreover, these genes showed the highest ranking
position when the commonly expressed genes of HUVEC
and HSaVEC were analyzed (Additional file 3).
It has been speculated that dysregulated expression of
cytokines and chemokines following RV infection dis-
rupts cellular processes in the developing fetus, thereby
contributing to CRS. However, data on which chemo-
kines are produced during RV infection and how they
affect the developing fetus are missing. Using the pri-
mary endothelial cell model system, we examined
whether increased expression of chemotactic cytokines
was detected on the protein level by a chemokine array.
In concordance with the microarray results, an increase
of inflammatory chemokines was detected in the super-
natant of the RV-infected endothelial cells. Interestingly,
CCL5, CXCL10, and CXCL11 — which have been re-
ported to play a key role in the pathogenesis of cardio-
vascular disease [22–24] — appeared to be most
upregulated (more than 10-fold). CCL14 was the only
chemokine tested in the protein array for which a reduc-
tion was seen after infection in HUVEC, but not in
HSaVEC. CCL14 was also down-regulated 2.31 fold
(ANOVA p-value 5.27E-14) in the transcriptional profil-
ing analysis after infection of HUVEC. Interestingly,
CCL14 is highly expressed during early pregnancy by the
human endometrium [25] and has been implicated in
regulating the implantation of the embryo at the fetal-
maternal interface. The corresponding receptor of CCL14,
CCR1, which is mainly expressed by trophoblasts, was also
down-regulated 5.70-fold (ANOVA p-value 6.96E-03) as
detected by microarray analysis in HUVEC after RV infec-
tion. Thus, perturbation of this chemokine-receptor net-
work might interfere with maternal-fetal communication
and contribute to RV-associated embryo resorption or dis-
turbed placental and fetal development. Interestingly, this
receptor was also found to be down-regulated following in-
fection of monocytes with another teratogen, HCMV [26].
However, the role of RV infection in vivo on CCL14 and
CCR1 expression requires further investigation.
The most prominent clinical manifestations observed
in CRS patients are impairment in vision and hearing as
well as cardiovascular abnormalities. As of today, it is
not understood which mechanisms contribute to this
symptomatology or which genes are involved in the RV-
induced pathophysiology. However, dysfunction of the
sensory organs has been speculated to be a result of vas-
cular insufficiency causing nutrient deprivation rather
than being caused by direct viral damage [3]. By examin-
ing differences in gene expression between endothelial
cells of fetal and adult origin, we wanted to investigate
which genes might contribute to the RV-induced patho-
physiology in the fetus. GO term-based cluster analysis
of the down-regulated genes revealed that terms belong-
ing to sensory organ development (GO term “sensory
organ development”, “ear development”, “eye develop-
ment”) were only enriched for HUVEC. Gene expression
analysis by qPCR of RV-infected HUVEC also showed a
significant down-regulation of eight genes belonging to
this GO term.
While all genes encode proteins that possess functions
in sensory organ development, their molecular functions
and associated diseases are diverse. The genes ceroid-
lipofuscinosis, neuronal 8 (CLN8) and NHS play a role
during sensory organ development of the eye: CLN8 has a
function in lipid synthesis and transport and mutations are
associated with progressive epilepsy, mental retardation,
and vison impairment [27]. Mutations in the NHS gene
are associated with Nance-Horan-Syndrome, characterized
(See figure on previous page.)
Fig. 6 Donor-to-donor variation of sensory organ gene expression in HUVEC isolated from different donors. Two pools of HUVEC, with each pool
consisting of cells from three different donors, were infected with RV at an MOI of 5 and gene expression relative to non-infected cells was quantified
by qPCR 36 hpi. GAPDH was used for normalization. Bars denote mean ΔΔCT ± SEM with ΔΔCT values < 0 indicating up-regulation and ΔΔCT values > 0
indicating down-regulation. A two-tailed unpaired t-test was used to determine statistically significant differences in gene expression using ΔCT values
and is indicated by an asterisk (*, p≤ 0.05; **, p≤ 0.01)
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by ocular abnormalities such as cataracts. It was demon-
strated that the NHS protein is a regulator of actin remod-
eling, and it was speculated that its function is required for
maintaining cell morphology during embryogenesis [28].
The genes FZD3, JAG2, NOG and SLC25A27, encode
for proteins that are attributed to ear development. The
function of FZD3 protein is still under debate, but recent
data indicate that FZD3 is involved in regulating axonal
navigation during embryonic development [29]. The pu-
tative Notch-ligand, JAG2, was shown to control the
number of sensory hair cells that form the organ of corti
in the cochlea of the inner ear [30, 31]. The gene prod-
uct of NOG is required for neural tube growth and pat-
terning, but was also demonstrated to interfere with
bone morphogenetic protein (BMP) signaling, thereby
blocking sensory organ morphogenesis of the inner ear
in different animal models [32–34]. The function of the
mitochondria uncoupling protein (UCP4), encoded by
SLC25A27, is still a matter of debate; however, expression
of this protein has been found in neurosensory cells of the
inner ear supporting the hypothesis that UCP4 plays a role
in functional maturation of the inner ear [35].
The gene product of FGFR2 and MYO7A are suspected
to function both in ear and eye development. Mutations
in the FGFR2 gene have been associated with skeletal ab-
normalities [36] and Lacrimo-auriculo-dento-digital
(LADD [MIM 149730]) syndrome, a disorder character-
ized by hearing loss, deformity in the network of struc-
tures of the eye, lacrimal-duct aplasia, and malformations
of teeth, forearms, and fingers. Defects in MYO7A have
been shown to cause Usher syndrome, a disorder charac-
terized by sensorineural hearing loss combined with retin-
itis pigmentosa [37, 38].
FZD3, NOG and SLC25A27 were also shown to be
down-regulated in HSaVEC, indicating that the regula-
tion of these genes seems to be independent of cell ori-
gin. Nevertheless, one could imagine that interference
with the expression of these three genes during embry-
onic development would have a profound effect on the
organism, whereas the effect would not be as dramatic
in the adult. In contrast, ADAMTS18, CLN8, RDH10
and TNPO1 were shown to be up-regulated following in-
fection in HSaVEC, indicating that gene regulation dif-
fers for these genes between the endothelial cells.
Development of organs belonging to the sensory sys-
tem is complex and must be precisely coordinated and
controlled by intrinsic and extrinsic factors. Interference
with the expression of genes involved in these processes
may be fatal during embryogenesis and, furthermore, the
down-regulation of these genes may give some explana-
tions as to why RV infection is often associated with vi-
sion and hearing loss, but causes only mild and transient
symptoms in patients infected postnatally. Interestingly,
in a study by M. P. Adamo, et al. [14], the here detected
down-regulated genes belonging to the GO term
“sensory organ development” were not shown to be dif-
ferentially regulated in their transcriptome analysis of
the RV-infected human embryonic fibroblasts (HEF).
In order to the see common and different patterns in
gene expression between our primary cells and the cell
lines used in the transcriptome analysis carried out by M.
P. Adamo, et al. [14], the gene lists of the cells of fetal and
adult origin from both studies were compared with each
other (Additional file 4 (a)). In the study of M. P. Adamo,
et al. [14] gene expression of primary human embryo fi-
broblasts (HEF) was compared with a fibroblast cell line
from the human adult lung (Hs888Lu) following RV infec-
tion. Interestingly, when comparing the up-and down-
regulated genes between the HUVEC, HSaVEC, Hs888Lu,
and HEF, only a small overlap was detected. 86 genes were
commonly up-regulated in HUVEC and HEF, whereas
only 56 genes were commonly up-regulated in HSaVEC
and Hs888Lu. When comparing the down-regulated
genes, the overlap was even smaller with eight and three
commonly down-regulated genes for fetal and adult cells,
respectively. Not surprisingly, the commonly up-
regulated genes of fetal cells showed an enrichment
of GO-terms involved in viral defense mechanisms
(Additional file 4 (b)). For the other commonly regu-
lated genes, no GO-terms were enriched. However, most
of the up-regulated genes of adult cells also contained
pro-inflammatory genes involved in viral defense mecha-
nisms. Many antiviral strategies are switched on upon viral
infection and are conserved, even if different viruses and
cell types are analyzed. Thus, it is not surprising that anti-
viral genes were up-regulated in the endothelial cells as
well as HEF and Hs888Lu. However, a down-regulation of
genes belonging to the GO term “sensory organ develop-
ment” was only observed in our study in HUVEC. Our
use of a different virus strain and a later harvest time,
but more importantly the use of a different cell type,
might be responsible for this observation. Since damage
to the vascular endothelium has been observed in RV-
infected fetuses, we believe that our primary endothelial
(See figure on previous page.)
Fig. 7 Donor-to-donor variation of sensory organ gene expression in HSaVEC isolated from two different donors. HSaVEC obtained from two
different donors were infected with RV at an MOI of 5 and gene expression relative to non-infected cells was quantified by qPCR 36 hpi. GAPDH
was used for normalization. Bars denote mean ΔΔCT ± SEM with ΔΔCT values < 0 indicating up-regulation and ΔΔCT values > 0 indicating down-
regulation. A two-tailed unpaired t-test was used to determine statistically significant differences in gene expression using ΔCT values and is
indicated by an asterisk (*, p≤ 0.05)
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cell model is well suited for studying RV teratogenesis
and we speculate that the prominent clinical manifesta-
tions observed in CRS patients arise due to the deregu-
lation of sensory organ development genes in
endothelial cells.
Conclusion
The data presented here show that RV infection perturbs
the gene expression of its host. While most RV-induced
changes in transcription are common to endothelial cells
of fetal and adult origin (including those involved in
antiviral processes), we also detected unique gene ex-
pression changes depending on the cell type. Most re-
markably, a set of genes involved in sensory organ
development was down-regulated in the primary cells of
fetal origin. Since we could show that RV efficiently rep-
licates in the primary endothelial cells and since lesions
in the endothelium are a prominent finding in histo-
pathological studies of CRS fetuses, we propose that rep-
lication of RV in the fetal endothelium leads to a down-
regulation of genes required for ear and eye develop-
ment. It still remains unknown, however, which viral gene
products and cellular transcription factors are responsible
for the down-regulation of these genes. Nevertheless, the
down-regulation was mainly observed in the primary
endothelial cells of fetal origin. Thus, we believe that the
special cellular environment during fetal and embryonic
development plays a major role in this process and further
studies should be conducted with primary fetal endothelial
cells, such as HUVEC, rather than non-fetal cell lines.
Methods
Cell culture and viruses
Two pools of HUVEC (from three donors, Promocell) and
HSaVEC from two single donors, Promocell), between
passage three and eight, were cultured in Endothelial Cell
Growth Medium 2 (Promocell), supplemented with
100 μg/ml streptomycin and 100 U/ml penicillin in a hu-
midified atmosphere with 5 % CO2 at 37 °C. The clinical
isolate RVi/Wuerzburg.DEU/47.11 (Wb-12, genotype 2B)
was provided by Dr. Benedikt Weissbrich at the University
of Wuerzburg, propagated on Vero76 cells (ATCC) and
titered by the immunocolorimetric plaque assay [39].
For growth curve analysis, cells were seeded in 48-well
culture plates at a density of 5°104 cells per well and in-
fected with Wb-12 at an MOI of 5 the following day.
After adsorption for 2 h at 35 °C, the viral inoculum was
removed, the cells were washed three times with 1x PBS
and overlaid with 500 μl fresh medium. Supernatants
and cells were collected at the indicated time points.
The amount of intracellular virus was determined by
dissolving the cell pellet in 500 μl fresh medium
followed by three subsequent freeze-thaw cycles and
centrifugation for 5 min at 400∙g to remove debris. Virus
titer of the supernatant was determined by immunoco-
lorimetric plaque assay on Vero76 cells in duplicate.
Microarray, hybridization and gene expression analysis
For microarray analysis, 2°106 endothelial cells of fetal
and adult origin were infected with RV at an MOI of 10
and cells were lysed 36 h post infection with 600 μl RLT
buffer from the RNAeasy kit (Qiagen). RNA samples
from three independently RV-infected or mock-infected
cell cultures were used for each analysis. RNA-extraction,
microarray chip hybridization and processing were per-
formed by ATLAS Biolabs GmbH. DNA microarray ana-
lysis was carried out using the Affymetrix Human
Genome U133 Plus 2.0 array (Affymetrix). The obtained
data were further processed, checked for quality, and fil-
tered using the Affymetrix Expression Console Software.
Gene level analysis was further conducted with Affyme-
trix Transcriptome Analysis Console 2.0 software.
Analysis of enriched biological processes and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways
of the differentially expressed genes after RV infection
was carried out using the Cytoscape v 3.1.1 plugin
ClueGO v2.1.1 [40]. Processes and pathways that pos-
sessed a p-value of ≤ 0.01 were displayed. Term and
group significance were calculated using a two-sided
hypergeometric test and a Bonferroni correction of the
p-value.
Quantitative real-time PCR (qPCR)
Total RNA from five independent infections of HUVEC
and six independent infections of HSaVEC, was har-
vested 36 h post infection using the RNAeasy Mini Kit
(Qiagen) according to manufacturer’s instructions. In
order to account for donor-to-donor variation, experi-
ments with HUVEC were conducted using two different
pools of cells (with each pool consisting of cells from
three different donors); furthermore, experiments with
HSaVEC were carried out on cells from two different do-
nors. Approximately 6 · 105 cells were used per RNA iso-
lation column and remaining DNA contaminants were
removed by a 30 min digest with 20 U of Turbo-DNase
(Ambion). RNA was eluted twice with RNase-free water
and the RNA concentration was determined using the
NanoDrop 8000 (Thermo Scientific). For cDNA gener-
ation, 1 μg of RNA was incubated for 1 h at 45 °C with
the following components: 1 unit RevertAid™ H minus
reverse transcriptase, 5 μM oligo(dT)18 primer, 1x reac-
tion buffer, 1 mM dNTP, and 20 U RiboLock RNase in-
hibitor (Fermentas). The reaction was terminated by
heating the mixture for 10 min at 70 °C. Reactions were
performed in a total volume of 25 μl, consisting of 1x
SYBR® Green PCR Master Mix (Life Technology), for-
ward and reverse primers (200 nM each) and 5 μl of
cDNA, dilutions ranging from 1:5 to 1:50. Cycling
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conditions were as follows: 95 °C for 15 min, followed
by 40 cycles of 95 °C for 15 s and 60 °C for 30 s using
the LightCycler 480 system (Roche). Fluorescence read-
ings were recorded at the last step. Melting curve ana-
lysis was performed after amplification to determine the
presence of nonspecific amplification products. All pri-
mer pairs used in this study are listed in Additional file
5. Primers for the amplification of NOG were purchased
from Biorad (Germany). Gene expression, normalized to
GAPDH, was determined using the ΔΔCt mathematical
model (Livak & Schmittgen, 2001). The paired one-
tailed t-test was used to determine statistically significant
differences in ΔCT values between non-infected and in-
fected groups.
Protein microarray and flow cytometry analysis
For protein microarray analysis, 2 · 105 HUVEC and
HSaVEC were infected with RV at an MOI of ten in two
independent experiments. Supernatants were collected
48 hpi and analyzed for the presence of chemokines
using the Proteome Profiler Human Chemokine Array
Kit (R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions. For flow cytometry
analysis, 1°105 HUVEC and HSaVEC were infected
with RV at an MOI of 5 and detached with trypsin at
various time points post infection. Following fixation
with 2 % paraformaldehyde for 20 min, cells were
permeabilized with 0.5 % saponine and stained with a
RV anti-capsid antibody (Meridian Life Science, USA)
and a secondary goat anti-mouse APC (Biolegend,
USA). Flow cytometry data were acquired on a FACS-
Calibur flow cytometer (BD Biosciences, USA) using
Cell Quest Pro software (BD Biosciences).
Additional files
Additional file 1: List of transcripts that were differentially
regulated after RV infection. (PDF 241 kb)
Additional file 2: Absolute chemokine expression following RV
infection. (PDF 761 kb)
Additional file 3: Ranking of commonly up- and down-regulated
genes in the endothelial cells following RV infection. (PDF 52 kb)
Additional file 4: Comparison of differentially regulated genes
following RV infection in HUVEC, HSaVEC, HEF and Hs888Lu.
(PDF 244 kb)
Additional file 5: List of primer sequences used for expression
analysis of genes belonging to the GO term “sensory organ
development” by qPCR. (PDF 7 kb)
Abbreviations
ADAMTS18: ADAM metallopeptidase with thrombospondin type 1 motif, 18;
ALDH1A2: aldehyde dehydrogenase 1 family, member A2; CLN8: ceroid-
lipofuscinosis, neuronal 8; CPE: cytopathic effect; CRS: congenital rubella
syndrome; DSCAM: down syndrome cell adhesion molecule; FGFR2: fibroblast
growth factor receptor 2; FZD3: frizzled class receptor 3; GO: gene ontology;
HSaVEC: human saphenous vein endothelial cells; HUVEC: human umbilical
vein endothelial cells; JAG2: jagged 2; KEGG: Kyoto Encyclopedia of Genes
and Genomes; MYO3A: myosin 3A; MYO7A: myosin 7A; NHS: Nance-Horan
syndrome; NOG: noggin; NTRK3: neurotrophic tyrosine kinase, receptor, type
3; PDGFRA: platelet-derived growth factor receptor, alpha polypeptide;
RDH10: retinol dehydrogenase 10; RV: rubella virus; SLC25A27: solute carrier
family 25, member 27; TNPO1: transportin 1; TRPM1: transient receptor
potential cation channel, subfamily M, member 1; TSPAN12: tetraspanin 12.
Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
HG was responsible for design, conduct, study completion and statistical
analysis. HG and AL were responsible for writing the manuscript. MB was
responsible for the viral growth curve, detection of viral protein by flow
cytometry, infection for microarray analysis and statistical analysis. JN and HG
carried out the chemokine profiler and quantitative qPCR. AL and NF
participated in the statistical analysis. PR carried out the microscopic analysis.
CC and LP participated in the study design and work with the primary
endothelial cells. AM was the principal investigator and was responsible for
research design and coordination. All authors read and approved the
manuscript.
Acknowledgment
We would like to thank Dr. Benedikt Weissbrich for providing the Wb-12
strain used in this work. This research was supported by the Robert Koch
Institute.
Author details
1Division 12, “Measles, Mumps, Rubella, and Viruses Affecting
Immunocompromised Patients”, Robert Koch Institute, 13353 Berlin,
Germany. 2Institute of Molecular Life Sciences, University of Zurich, 8057
Zurich, Switzerland. 3Unit “Diagnostics and Pathogen Characterisation”,
Bundesinstitut für Risikobewertung, 12277 Berlin, Germany. 4Institut für
Virologie, Universität Leipzig, Johannisallee 30, 04103 Leipzig, Germany.
5Division of Viral Diseases, Centers for Disease Control and Prevention, 1600
Clifton Rd, Atlanta, GA 30333, USA.
Received: 30 October 2015 Accepted: 25 January 2016
References
1. Hobman T, Chantler J. In: Knipe DM, Howley PM, editors. Fields Virology Fifth
ed, vol One. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 963–90.
2. Saraswathy TS, Rozainanee MZ, Asshikin RN, Zainah S. Congenital rubella
syndrome: a review of laboratory data from 2002 to 2011. Southeast Asian J
Trop Med Public Health. 2013;44:429–35.
3. Webster WS. Teratogen update: congenital rubella. Teratology. 1998;
58:13–23.
4. Plotkin SA. Routes of fetal infection and mechanisms of fetal damage. Am J
Dis Child. 1975;129:444–9.
5. Kistler GS. Cytoplasmic tubuloreticular complexes and nuclear bodies in
cells of rubella-infected human embryos and fetuses (author’s transl). Beitr
Pathol. 1975;155:101–38.
6. Menser MA, Reye RD. The pathology of congenital rubella: a review written
by request. Pathology. 1974;6:215–22.
7. Tondury G, Smith DW. Fetal rubella pathology. J Pediatr. 1966;68:867–79.
8. Gregg NM. Congenital cataract following German measles in the mother.
Trans Ophthalmol Soc Aust. 1941;3:35–46.
9. Rowe RD. Cardiovascular disease in the rubella syndrome. Cardiovasc Clin.
1973;5:61–80.
10. Banatvala JE, Brown DW. Rubella. Lancet. 2004;363:1127–37.
11. Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward
control of rubella and prevention of congenital rubella syndrome–
worldwide, 2009. J Infect Dis. 2011;204 Suppl 1:S24–7.
12. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin
Microbiol Rev. 2000;13:571–87.
13. Knipe DM, Howley PM. Fields Virology. Philadelphia: Lippincott Williams &
Wilkins; 2007.
14. Adamo MP, Zapata M, Frey TK. Analysis of gene expression in fetal and
adult cells infected with rubella virus. Virology. 2008;370:1–11.
Geyer et al. Virology Journal  (2016) 13:21 Page 16 of 17
15. Mo XY, Ma W, Zhang Y, Zhao H, Deng Y, Yuan W, et al. Microarray analyses
of differentially expressed human genes and biological processes in ECV304
cells infected with rubella virus. J Med Virol. 2007;79:1783–91.
16. Petruzziello R, Orsi N, Macchia S, Rieti S, Frey TK, Mastromarino P. Pathway
of rubella virus infectious entry into Vero cells. J Gen Virol. 1996;77:303–8.
17. Hemphill ML, Forng RY, Abernathy ES, Frey TK. Time Course of Virus-Specific
Macromolecular Synthesis During Rubella Virus Infection in Vero Cells.
Virology. 1988;162:65–75.
18. Frey TK. Molecular biology of rubella virus. Adv Virus Res. 1994;44:69–160.
19. Perelygina L, Zheng Q, Metcalfe M, Icenogle J. Persistent infection of human
fetal endothelial cells with rubella virus. PLoS ONE. 2013;8:e73014.
20. Bardeletti G, Tektoff J, Gautheron D. Rubella virus maturation and
production in two host cell systems. Intervirology. 1979;11:97–103.
21. Sedwick WD, Sokol F. Nucleic acid of rubella virus and its replication in
hamster kidney cells. J Virol. 1970;5:478–89.
22. Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular
mechanisms and clinical implications. Clin Sci (Lond). 2009;117:95–109.
23. van den Borne P, Quax PH, Hoefer IE, Pasterkamp G. The multifaceted
functions of CXCL10 in cardiovascular disease. Biomed Res Int. 2014;
2014:893106.
24. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Oie E, Otterdal K, et al.
Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2008;
28:1909–19.
25. Hannan NJ, Jones RL, White CA, Salamonsen LA. The chemokines, CX3CL1,
CCL14, and CCL4, promote human trophoblast migration at the feto-
maternal interface. Biol Reprod. 2006;74:896–904.
26. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. Transcriptome
analysis reveals human cytomegalovirus reprograms monocyte
differentiation toward an M1 macrophage. J Immunol. 2008;181:698–711.
27. Mahajnah M, Zelnik N. Phenotypic heterogeneity in consanguineous
patients with a common CLN8 mutation. Pediatr Neurol. 2012;47:303–5.
28. Brooks SP, Coccia M, Tang HR, Kanuga N, Machesky LM, Bailly M, et al. The
Nance-Horan syndrome protein encodes a functional WAVE homology
domain (WHD) and is important for co-ordinating actin remodelling and
maintaining cell morphology. Hum Mol Genet. 2010;19:2421–32.
29. Qu Y, Huang Y, Feng J, Alvarez-Bolado G, Grove EA, Yang Y, et al. Genetic
evidence that Celsr3 and Celsr2, together with Fzd3, regulate forebrain
wiring in a Vangl-independent manner. Proc Natl Acad Sci U S A. 2014;111:
E2996–3004.
30. Kiernan AE, Cordes R, Kopan R, Gossler A, Gridley T. The Notch ligands DLL1
and JAG2 act synergistically to regulate hair cell development in the
mammalian inner ear. Development. 2005;132:4353–62.
31. Lanford PJ, Lan Y, Jiang R, Lindsell C, Weinmaster G, Gridley T, et al. Notch
signalling pathway mediates hair cell development in mammalian cochlea.
Nat Genet. 1999;21:289–92.
32. Chang W, Nunes FD, De Jesus-Escobar JM, Harland R, Wu DK. Ectopic
noggin blocks sensory and nonsensory organ morphogenesis in the
chicken inner ear. Dev Biol. 1999;216:369–81.
33. Gerlach LM, Hutson MR, Germiller JA, Nguyen-Luu D, Victor JC, Barald KF.
Addition of the BMP4 antagonist, noggin, disrupts avian inner ear
development. Development. 2000;127:45–54.
34. McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP.
Noggin-mediated antagonism of BMP signaling is required for growth and
patterning of the neural tube and somite. Genes Dev. 1998;12:1438–52.
35. Smorodchenko A, Rupprecht A, Fuchs J, Gross J, Pohl EE. Role of
mitochondrial uncoupling protein 4 in rat inner ear. Mol Cell Neurosci. 2011;
47:244–53.
36. Merrill AE, Sarukhanov A, Krejci P, Idoni B, Camacho N, Estrada KD, et al.
Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient
canonical FGF signaling. Am J Hum Genet. 2012;90:550–7.
37. Jaijo T, Aller E, Beneyto M, Najera C, Graziano C, Turchetti D, et al. MYO7A
mutation screening in Usher syndrome type I patients from diverse origins.
J Med Genet. 2007;44:e71.
38. Eudy JD, Sumegi J. Molecular genetics of Usher syndrome. Cell Mol Life Sci.
1999;56:258–67.
39. Chen MH, Zhu Z, Zhang Y, Favors S, Xu WB, Featherstone DA, et al. An
indirect immunocolorimetric assay to detect rubella virus infected cells. J
Virol Methods. 2007;146:414–8.
40. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al.
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene
ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–3.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Geyer et al. Virology Journal  (2016) 13:21 Page 17 of 17
